Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Pirtobrutinib as a Game Changer for Patients With CLL
"Courage is not the absence of fear, , but rather the judgment that something else is more
Podcast: Cannabis and Cannabinoids in Adults with Cancer Guideline
Venetoclax/Azacitidine Yields Sustained Survival in AML
New therapeutic targets for elderly patients diagnosed with diffuse large B-cell lymphoma.
Setting Expectations When Starting a New Cancer Treatment
CAR-T shows ‘superior outcomes’ in adults with post-transplant relapsed leukemia
Accelerated Approval Granted to First CAR T-Cell Therapy for Relapsed or Refractory CLL/SLL
Those with blood cancers ‘can’t rely on vaccination’ for protection from severe COVID-19
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Pirtobrutinib as a Game Changer for Patients With CLL
"Courage is not the absence of fear, , but rather the judgment that something else is more
Podcast: Cannabis and Cannabinoids in Adults with Cancer Guideline
Venetoclax/Azacitidine Yields Sustained Survival in AML
New therapeutic targets for elderly patients diagnosed with diffuse large B-cell lymphoma.
Setting Expectations When Starting a New Cancer Treatment
CAR-T shows ‘superior outcomes’ in adults with post-transplant relapsed leukemia
Accelerated Approval Granted to First CAR T-Cell Therapy for Relapsed or Refractory CLL/SLL
Those with blood cancers ‘can’t rely on vaccination’ for protection from severe COVID-19
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
